The global market for diagnostics in low-resource settings does not meet the needs of the millions of people living with HIV, TB, HPV, Hepatitis and other diseases. Current testing coverage is low yet demand continues to grow sharply in the face of limited resources, highlighting the need for innovative approaches to enable robust, efficiently utilized testing capacity, and a healthy and secure market with competitive supply.
To help address the above needs, the Integrated Diagnostics Consortium (IDC) was formed in October 2017. The aim of the IDC is to enable better coordinated procurement and deployment of platform-based diagnostic technologies to support HIV, TB, HPV, and Hepatitis testing scale-up. IDC stakeholders include major donors and procuring countries, implementing partners and technical agencies. Members include representatives of the governments of India, Kenya and South Africa, ASLM, CDC, CHAI, EGPAF, FIND, MSF, MSH, Solthis, Stop TB, The Global Fund, UNICEF, Unitaid, PEPFAR (OGAC, CDC, USAID) and WHO.
More information about the IDC will be available here soon. In the meantime, please view our current IDC resources here.